12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights significant pre-market movements in health care stocks on Friday. Notable gainers include Venus Concept (VERO), Adlai Nortye (ANL), BioCardia (BCDA), Geron (GERN), Seelos Therapeutics (SEEL), and Indaptus Therapeutics (INDP). On the losing side, Biomea Fusion (BMEA), Xylo Technologies (XYLO), Exicure (XCUR), Virax Biolabs Group (VRAX), Monopar Therapeutics (MNPR), and Geovax Labs (GOVX) saw declines.
June 07, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Adlai Nortye shares rose by 56.64% to $6.72 in pre-market trading, boosting its market value.
The substantial increase in share price suggests positive developments or investor sentiment for Adlai Nortye.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
BioCardia shares increased by 52.57% to $6.66 in pre-market trading, enhancing its market value.
The significant rise in share price indicates positive news or sentiment for BioCardia.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Geron stock rose by 22.36% to $4.76 in pre-market trading, increasing its market value.
The notable increase in share price suggests positive developments or investor sentiment for Geron.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Indaptus Therapeutics stock rose by 13.21% to $2.98 in pre-market trading, increasing its market value.
The rise in share price suggests positive developments or investor sentiment for Indaptus Therapeutics.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 100
POSITIVE IMPACT
Seelos Therapeutics stock moved up by 14.66% to $1.29 in pre-market trading, boosting its market value.
The increase in share price indicates positive sentiment or news impacting Seelos Therapeutics.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 100
POSITIVE IMPACT
Venus Concept shares surged by 135.2% to $1.38 in pre-market trading, significantly increasing its market value.
The significant increase in share price indicates strong positive sentiment or news impacting Venus Concept.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Biomea Fusion stock decreased by 62.5% to $4.23 in pre-market trading, significantly reducing its market value.
The significant drop in share price indicates negative news or sentiment impacting Biomea Fusion.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Geovax Labs shares decreased by 14.54% to $1.47 in pre-market trading, reducing its market value.
The drop in share price suggests negative developments or investor sentiment for Geovax Labs.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Monopar Therapeutics shares declined by 14.92% to $0.79 in pre-market trading, reducing its market value.
The decline in share price indicates negative sentiment or news impacting Monopar Therapeutics.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Virax Biolabs Group stock declined by 18.28% to $1.61 in pre-market trading, reducing its market value.
The significant drop in share price suggests negative news or sentiment impacting Virax Biolabs Group.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Exicure shares decreased by 18.55% to $0.39 in pre-market trading following their Q4 earnings release.
The decline in share price following the Q4 earnings release indicates negative investor reaction to Exicure's financial performance.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Xylo Technologies stock decreased by 19.79% to $1.5 in pre-market trading, reducing its market value.
The notable drop in share price suggests negative developments or investor sentiment for Xylo Technologies.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100